Pfizer and its German partner on Tuesday launched a clinical study that will evaluate an updated version of their COVID-19 vaccine. The updated formulation targets Omicron, a variant of the CCP (Chinese Communist Party) virus. Omicron became dominant in the United States last month; the Pfizer-BioNTech vaccine has proven much less effective, especially against infection, versus the…
Pfizer Begins Study Evaluating COVID-19 Vaccine That Targets Omicron Variant
January 25, 2022
admin
BioNTechBrightBusiness & EconomyBusinesses in COVID-19CCP VirusEditor's PicksHealth NewsMind & BodyPfizerVaccines & Safety
0 Comment
Pfizer and BioNTech Announce Collaboration on mRNA Shingles Vaccines
Pfizer and its German partner on Tuesday announced they will work together on a shingles vaccine that utilizes messenger RNA technology. Pfizer and BioNTech created one of the most-used COVID-19 vaccines in the world by using the technology, which had never been cleared for use in any countries before the pandemic. Under a new agreement,…
2 Doses of China’s Sinovac Vaccines Ineffective Against Omicron: Hong Kong Study
A new study found that two doses of China’s Sinovac COVID-19 vaccine didn’t generate appreciable numbers of antibodies against the new, highly infectious, omicron variant. The study tested the blood from 25 people who were fully vaccinated with Sinovac’s Coronavac. None of them “contain sufficient antibodies to neutralize the Omicron variant,” researchers at the Department…
Live Q&A: FDA Wants 75 Years to Release Pfizer Data; China’s Economy Braces as Evergrande Defaults
The Food and Drug Administration (FDA) wants 75 years before it fully makes public its data on the Pfizer and BioNTech vaccines. And in other news, China’s Evergrande has defaulted, and the world is now bracing for the potential economic impact. In this live Q&A with Crossroads host Joshua Philipp, we’ll discuss these stories and…
Pfizer-BioNTech COVID-19 Vaccine Less Effective Against Omicron: Companies
The Pfizer-BioNTech COVID-19 vaccine is less effective against the Omicron virus variant than other strains of the CCP virus, the companies said Wednesday, citing a study they ran. Scientists found on average a more than 25-fold reduction in neutralizing antibodies against the Omicron variant compared to the wild type, “indicating that two doses of BNT162b2 may…
Pfizer, BioNTech, Moderna Making $1,000 Every Second From COVID-19 Vaccines: People’s Vaccine Alliance
November 17, 2021
admin
BioNTechBusiness & EconomyBusinesses in COVID-19CCP VirusCOVID-19 VaccinesInternationalModernaPfizerVaccines & SafetyWorld
0 Comment
Pfizer, BioNTech, and Moderna are making thousands of dollars in combined profits every minute from their COVID-19 vaccines, while less than 1 percent of each company’s doses have gone to the world’s poorest countries, according to a new analysis by the People’s Vaccine Alliance (PVA). PVA, a coalition of organizations campaigning for wider access to COVID-19 vaccines, based its calculations…
Pfizer Partner to Seek Approval Soon for Vaccine for 5- to 11-Year-Olds: Executives
September 10, 2021
admin
AMERICABioNTechBusiness & EconomyCCP VirusCompaniesInternationalPfizerUSUS NewsVaccines & SafetyWorld
0 Comment
BioNTech, which developed one of the world’s most commonly used COVID-19 vaccines along with Pfizer, is attempting to gain approval soon for vaccinating children between the ages of 5 and 11 across the world, top executives with the firm announced Friday. “Already over the next few weeks we will file the results of our trial…
Vaccine-Maker BioNTech Sees 2nd-Quarter Profits Soar
German pharmaceutical giant BioNTech, which jointly with Pfizer developed the first COVID-19 vaccine to be granted emergency use authorization by U.S. regulators, saw its profits surge in the second quarter of 2021. In an earnings report released on Monday, the Mainz-based company said that it made a net profit of nearly $3.3 billion between April…
BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study
July 18, 2021
admin
antibodyBioNTechbooster shotCCP VirusChinaChinese RegimeHong KongPfizer BioNTechSinovacVaccines & Safety
0 Comment
A new study by researchers in Hong Kong has found that recipients of BioNTech’s Comirnaty COVID-19 vaccine generate 10 times more antibodies than the Chinese CoronaVac vaccine made by Sinovac. The study reported that even after receiving their first BioNTech dose, recipients’ antibody levels were higher than those who had received two doses of Sinovac. The…
BioNTech COVID-19 Vaccines Coming to Taiwan, Chinese Agent Says
July 12, 2021
admin
Asia & PacificBioNTechCCP VirusChinaCOVID-19 VaccinesEuropeInternationalInternational RelationsSpecial TopicsTaiwanVaccines & SafetyWorld
0 Comment
TAIPEI—The Chinese sales agent for Germany’s BioNTech SE said on Sunday it had signed a deal to provide 10 million COVID-19 vaccine doses to Taiwan, part of a drawn-out and highly politicized process for the island to access the shots. Taiwan’s government has tried for months to buy the vaccine directly from BioNTech and has…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`